Use of antipsychotic medications in older home-care patients. Report from nine European countries

2.50
Hdl Handle:
http://hdl.handle.net/2336/42335
Title:
Use of antipsychotic medications in older home-care patients. Report from nine European countries
Authors:
Alanen, Hanna-Mari; Finne-Soveri, Harriet; Fialova, Daniela; Topinkova, Eva; Jonsson, Palmi V; Soerbye, Liv Wergeland; Bernabei, Roberto; Leinonen, Esa
Citation:
Aging Clin Exp Res. 2008, 20(3):260-5
Issue Date:
1-Jun-2008
Abstract:
BACKGROUND AND AIMS: Data on the use of antipsychotics among older people in need of regular home care services are rare. The aim of this study was to ascertain the differences in the use and type of antipsychotic medications between European home-care sites. METHODS: A cross-sectional study was designed by means of RAI (Resident Assessment Instrument for Home Care) assessments. A random sample of 3251 assessments was gathered during the period September 2001-January 2002 from home care patients aged 65 and over in nine European countries (Czech Republic, Denmark, Finland, Germany, Iceland, Italy, Netherlands, Norway and United Kingdom). RESULTS: Two hundred of the home care patients (6.2%) received antipsychotic medication. The prevalence of the use of one or more antipsychotics varied widely between study sites, ranging from 3.0% in Denmark to 12.4% in Finland. Factors independently associated with the use of antipsychotics were: delusions (OR 3.09, 95% CI 1.66-5.76), any diagnosis of dementia (OR 2.57, 95% CI 1.70-3.87), youngest age group (65-74 yrs) (OR 2.37, 95% CI 1.53-3.66) and hallucinations (OR 2.28, 95% CI 1.17-4.45). Concomitant use of anxiolytics (OR 2.32, 95% CI 1.58- 3.41), hypnotics (OR 2.08, 95% CI 1.44-3.03) and antidepressants (OR 2.06, 95% CI 1.41-3.00) together with signs of depression (OR 1.78, 95% CI 1.24- 2.56), moderate to severe cognitive impairment (OR 1.30, 95% CI 1.12-1.51) and residing in Finland (OR 2.52, 95% CI 1.21-5.24) or Italy (OR 2.15, 95% CI 1.10-4.19) were associated with the use of antipsychotics. The most commonly used antipsychotic agent was risperidone (n=42, 21%). CONCLUSIONS: The frequency of antipsychotic drug use in older home-care patients varied considerably among the European countries studied. Antipsychotic drug treatment in older home-care recipients seems to be less common than in residents in long-term institutional care, and more common than among the independently-living elderly.
Description:
To access publisher full text version of this article. Please click on the hyperlink in Additional Links field
Additional Links:
http://www.kurtis.it/abs/index.cfm?id_articolo_numero=4666

Full metadata record

DC FieldValue Language
dc.contributor.authorAlanen, Hanna-Mari-
dc.contributor.authorFinne-Soveri, Harriet-
dc.contributor.authorFialova, Daniela-
dc.contributor.authorTopinkova, Eva-
dc.contributor.authorJonsson, Palmi V-
dc.contributor.authorSoerbye, Liv Wergeland-
dc.contributor.authorBernabei, Roberto-
dc.contributor.authorLeinonen, Esa-
dc.date.accessioned2008-12-15T10:07:57Z-
dc.date.available2008-12-15T10:07:57Z-
dc.date.issued2008-06-01-
dc.date.submitted2008-12-15-
dc.identifier.citationAging Clin Exp Res. 2008, 20(3):260-5en
dc.identifier.issn1594-0667-
dc.identifier.pmid18594194-
dc.identifier.urihttp://hdl.handle.net/2336/42335-
dc.descriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links fielden
dc.description.abstractBACKGROUND AND AIMS: Data on the use of antipsychotics among older people in need of regular home care services are rare. The aim of this study was to ascertain the differences in the use and type of antipsychotic medications between European home-care sites. METHODS: A cross-sectional study was designed by means of RAI (Resident Assessment Instrument for Home Care) assessments. A random sample of 3251 assessments was gathered during the period September 2001-January 2002 from home care patients aged 65 and over in nine European countries (Czech Republic, Denmark, Finland, Germany, Iceland, Italy, Netherlands, Norway and United Kingdom). RESULTS: Two hundred of the home care patients (6.2%) received antipsychotic medication. The prevalence of the use of one or more antipsychotics varied widely between study sites, ranging from 3.0% in Denmark to 12.4% in Finland. Factors independently associated with the use of antipsychotics were: delusions (OR 3.09, 95% CI 1.66-5.76), any diagnosis of dementia (OR 2.57, 95% CI 1.70-3.87), youngest age group (65-74 yrs) (OR 2.37, 95% CI 1.53-3.66) and hallucinations (OR 2.28, 95% CI 1.17-4.45). Concomitant use of anxiolytics (OR 2.32, 95% CI 1.58- 3.41), hypnotics (OR 2.08, 95% CI 1.44-3.03) and antidepressants (OR 2.06, 95% CI 1.41-3.00) together with signs of depression (OR 1.78, 95% CI 1.24- 2.56), moderate to severe cognitive impairment (OR 1.30, 95% CI 1.12-1.51) and residing in Finland (OR 2.52, 95% CI 1.21-5.24) or Italy (OR 2.15, 95% CI 1.10-4.19) were associated with the use of antipsychotics. The most commonly used antipsychotic agent was risperidone (n=42, 21%). CONCLUSIONS: The frequency of antipsychotic drug use in older home-care patients varied considerably among the European countries studied. Antipsychotic drug treatment in older home-care recipients seems to be less common than in residents in long-term institutional care, and more common than among the independently-living elderly.en
dc.language.isoenen
dc.publisherEditrice Kurtisen
dc.relation.urlhttp://www.kurtis.it/abs/index.cfm?id_articolo_numero=4666en
dc.subject.meshAgeden
dc.subject.meshAged, 80 and overen
dc.subject.meshAntipsychotic Agentsen
dc.subject.meshEuropeen
dc.subject.meshFemaleen
dc.subject.meshHome Care Servicesen
dc.subject.meshHumansen
dc.subject.meshLogistic Modelsen
dc.subject.meshMaleen
dc.subject.meshTime Factorsen
dc.titleUse of antipsychotic medications in older home-care patients. Report from nine European countriesen
dc.typeArticleen
dc.contributor.departmentUniversity of Tampere, Medical School, FIN- 33014 Tampere, Finland. hanna-mari.alanen@uta.fien
dc.identifier.journalAging clinical and experimental researchen

Related articles on PubMed

All Items in Hirsla are protected by copyright, with all rights reserved, unless otherwise indicated.